NYSE:EVHC - Envision Healthcare Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$45.99
+0.30 (1.20%)
Get New Envision Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EVHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EVHC

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Envision Healthcare in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $45.99.

This chart shows the closing price for EVHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Envision Healthcare. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/10/2018Cantor FitzgeraldReiterated RatingHold$46.00Low
6/12/2018Canaccord GenuityDowngradeBuy ➝ Hold$48.00 ➝ $46.00Low
6/12/2018Raymond JamesReiterated RatingStrong-Buy ➝ Market Perform$51.00Low
6/12/2018SunTrust BanksDowngradeBuy ➝ HoldLow
6/12/2018Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformLow
6/11/2018Robert W. BairdDowngradeOutperform ➝ NeutralMedium
6/11/2018William BlairDowngradeOutperform ➝ Market PerformMedium
5/9/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$46.00 ➝ $48.00Medium
4/11/2018Robert W. BairdSet Price TargetBuy$50.00High
4/11/2018Jefferies Financial GroupSet Price TargetBuy$46.00High
3/15/2018Jefferies Financial GroupSet Price TargetBuy$46.00Low
3/7/2018Robert W. BairdReiterated RatingOutperform$45.00 ➝ $50.00Medium
3/2/2018MizuhoSet Price TargetHold$38.00Low
3/1/2018Royal Bank of CanadaReiterated RatingBuy$48.00Low
3/1/2018SunTrust BanksBoost Price TargetPositive ➝ Buy$45.00Low
2/28/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$32.00 ➝ $46.00High
2/28/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$37.00 ➝ $40.00High
2/26/2018Robert W. BairdSet Price TargetBuy$45.00High
2/21/2018Cantor FitzgeraldReiterated RatingHold$37.00Low
2/7/2018Jefferies Financial GroupSet Price TargetBuy$46.00High
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Positive$36.00 ➝ $43.50Low
1/24/2018MizuhoSet Price TargetHold$35.00Low
1/10/2018StephensReiterated RatingHold$34.00Low
1/5/2018Cantor FitzgeraldReiterated RatingHold$37.00High
12/21/2017SunTrust BanksSet Price TargetBuy$40.00Medium
12/19/2017Jefferies Financial GroupSet Price TargetBuy$41.00Medium
12/13/2017Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$35.00Low
12/11/2017Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$36.00High
11/17/2017MizuhoSet Price TargetNeutral ➝ Neutral$57.00 ➝ $31.00N/A
11/14/2017Robert W. BairdSet Price TargetBuy$35.00N/A
11/14/2017Cantor FitzgeraldReiterated RatingHold$30.00N/A
11/14/2017KeyCorpSet Price TargetBuy$40.00N/A
11/3/2017Robert W. BairdLower Price TargetOutperform$70.00 ➝ $35.00N/A
11/2/2017OppenheimerLower Price TargetOutperform$77.00 ➝ $40.00N/A
11/2/2017KeyCorpLower Price TargetOverweight$67.00 ➝ $37.00N/A
11/2/2017Canaccord GenuityReiterated RatingBuy$68.00 ➝ $32.00N/A
11/2/2017CitigroupDowngradeBuy ➝ Neutral$31.00N/A
11/2/2017StephensDowngradeOverweight ➝ Equal Weight$32.00N/A
11/2/2017Bank of AmericaDowngradeBuy ➝ Neutral$32.00N/A
11/1/2017KeyCorpSet Price TargetBuy$67.00N/A
11/1/2017Jefferies Financial GroupSet Price TargetBuy$71.00N/A
11/1/2017Cantor FitzgeraldDowngradeOverweight ➝ Neutral$30.00N/A
10/31/2017MizuhoSet Price TargetHold$57.00N/A
10/17/2017Robert W. BairdReiterated RatingBuy$70.00N/A
10/15/2017SunTrust BanksSet Price TargetBuy$55.00N/A
10/9/2017Bank of AmericaLower Price TargetBuy$72.00 ➝ $60.00N/A
8/24/2017Jefferies Financial GroupSet Price TargetBuy$71.00Low
8/9/2017MizuhoLower Price TargetNeutral$65.00 ➝ $57.00Medium
7/24/2017Cantor FitzgeraldReiterated RatingBuyHigh
7/4/2017Cantor FitzgeraldReiterated RatingBuy$80.00Low
6/27/2017Royal Bank of CanadaBoost Price TargetOutperform$72.00 ➝ $77.00Low
6/5/2017Royal Bank of CanadaReiterated RatingBuy$72.00Low
5/30/2017MizuhoLower Price TargetNeutral ➝ Neutral$70.00 ➝ $60.00Low
5/3/2017Jefferies Financial GroupReiterated RatingBuy$75.00 ➝ $71.00Medium
5/3/2017Royal Bank of CanadaReiterated RatingBuy$72.00High
4/21/2017Jefferies Financial GroupSet Price TargetBuy$82.00 ➝ $75.00Low
4/18/2017Canaccord GenuityReiterated RatingBuy$86.00Medium
4/6/2017Cantor FitzgeraldReiterated RatingBuy$80.00Low
3/21/2017BarclaysReiterated RatingOverweightLow
3/16/2017Cantor FitzgeraldReiterated RatingOverweightLow
3/1/2017Royal Bank of CanadaReiterated RatingOutperform$87.00 ➝ $80.00N/A
3/1/2017Jefferies Financial GroupReiterated RatingBuy$90.00 ➝ $82.00N/A
3/1/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$87.00 ➝ $80.00N/A
1/5/2017Royal Bank of CanadaBoost Price TargetOutperform$30.00 ➝ $87.00N/A
12/29/2016Raymond JamesReiterated RatingStrong-Buy$100.00 ➝ $90.00N/A
12/15/2016BarclaysInitiated CoverageOverweightN/A
12/9/2016Canaccord GenuityReiterated RatingBuyN/A
12/9/2016The Goldman Sachs GroupInitiated CoverageBuyN/A
12/7/2016OppenheimerUpgradeMarket Perform ➝ Outperform$87.00N/A
12/7/2016UBS GroupUpgradeMarket Perform ➝ OutperformN/A
12/4/2016Jefferies Financial GroupSet Price TargetBuy$32.00N/A
(Data available from 11/27/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Envision Healthcare logo
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services. The company also offers ambulatory surgical centers (ASCs) services that provide surgical procedures across multiple specialties, including gastroenterology, ophthalmology, orthopedics, and others. It operated 264 ASCs in 35 states and the District of Columbia. In addition, it provides surgery services, such as management, oversight, and surgeon staffing for trauma surgery services; offers direct patient care and care coordination by clinicians outside the acute care setting through physician-led post-acute care services; and operates office-based medical practices that primarily focus on women's health, as well as provides physician staffing and related management services. Further, it offers medical transportation services in 41 states and the District of Columbia. The company offers its clinical solutions for health systems, payors, providers, and patients. Envision Healthcare Corporation was founded in 1992 and is based in Nashville, Tennessee.
Read More

Today's Range

Now: $45.99
Low: $45.99
High: $45.99

50 Day Range

MA: N/A

52 Week Range

Now: $45.99
Low: $23.77
High: $46.00

Volume

N/A

Average Volume

3,060,978 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Envision Healthcare?

The following Wall Street research analysts have issued stock ratings on Envision Healthcare in the last twelve months:
View the latest analyst ratings for EVHC.

What is the current price target for Envision Healthcare?

0 Wall Street analysts have set twelve-month price targets for Envision Healthcare in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Envision Healthcare in the next year.
View the latest price targets for EVHC.

What is the current consensus analyst rating for Envision Healthcare?

Envision Healthcare currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for EVHC.

What other companies compete with Envision Healthcare?

How do I contact Envision Healthcare's investor relations team?

Envision Healthcare's physical mailing address is 1A BURTON HILLS BOULEVARD, NASHVILLE TN, 37215. The company's listed phone number is 615-665-1283 and its investor relations email address is [email protected] The official website for Envision Healthcare is www.evhc.net.